Obesity research - Limitations of methods, measurements, and medications

被引:49
作者
Simons-Morton, DG [1 ]
Obarzanek, E [1 ]
Cutler, JA [1 ]
机构
[1] NHLBI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 295卷 / 07期
关键词
D O I
10.1001/jama.295.7.826
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:826 / 828
页数:3
相关论文
共 23 条
[21]   Estimated risks for developing obesity in the Framingham Heart Study [J].
Vasan, RS ;
Pencina, MJ ;
Cobain, M ;
Freiberg, MS ;
D'Agostino, RB .
ANNALS OF INTERNAL MEDICINE, 2005, 143 (07) :473-480
[22]   Randomized trial of lifestyle modification and pharmacotherapy for obesity [J].
Wadden, TA ;
Berkowitz, RI ;
Womble, LG ;
Sarwer, DB ;
Phelan, S ;
Cato, RK ;
Hesson, LA ;
Osei, SY ;
Kaplan, R ;
Stunkard, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2111-2120
[23]   Long-term weight loss with sibutramine - A randomized controlled trial [J].
Wirth, A ;
Krause, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (11) :1331-1339